BioSpace News Archive

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced its uAIFI Technology Platform for MR and uExcel Technology Platform for PET/CT at the China International Medical Equipment Fair.

Colorcon, a world leader in the development and supply of film coating systems and excipients, is proud to announce the expansion of its technical service capabilities with a new Containment Suite located in our Global Headquarters in Harleysville, PA, USA.

Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

Health Canada released the final re-evaluation decision on the risk to human health and the environment from the neonicotinoid pesticide imidacloprid.

XWPharma Ltd. today announced that data from clinical research of XW10172, a new chemical entity (NCE) in development for the treatment of sleep disorders associated with neurodegenerative diseases and narcolepsy, has been accepted for poster and oral presentation at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting, which will be held virtually from June 10-13, 2021.

reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid use disorder (OUD).

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to Director Finance & Accounting and Chief Financial Officer .

Beckman Coulter, a global clinical diagnostics leader, announced the launch of Access SARS-CoV-2 IgG, a fully-quantitative lab-based Immunoglobulin G serology test that measures the quantity of antibodies against the virus that causes COVID-19.

- Zogenix, a global biopharmaceutical company developing rare disease therapies, today launched the FINTEPLA Photo Diary, a community sharing, charitable campaign and contest.